Anti-IL-23α (Tildrakizumab), Humanized Antibody
Catalogue number:
A2159-100
Supplier:
BioVision
Size:
100 µg _$$_
Product is available in:
N/A
Shipping is calculated in checkout
This product is no longer available to order.
Antibody Host:
Recombinant
Species Reactivity:
Human
Antibody Isotype:
IgG1, kappa
Antibody Type:
Monoclonal
Immunogen:
Human IL-23α
- Data sheet: View or download
Product Description:
The research-grade biosimilar is a humanized IgG1 monoclonal antibody that specifically targets the p19 subunit of IL-23 and thereby inhibits the interaction with the IL-23 receptor. IL-23 is a cytokine that plays an important role in mediating inflammatory and immune responses. Binding of the antibody to Il-23 blocks the release of pro-inflammatory cytokines and chemokines associated with psoriasis. The original drug received approval from the FDA in 2018 to treat patients with moderate-to-severe plaque psoriasis who are candidates for systemic and phototherapy
Storage Temperature:
-80°C